Loan & DebtMay 11, 2026, 12:06 PM
Accendra Health Secures Debt Refinancing, Extends Maturities
AI Summary
Accendra Health, Inc. announced commitments for a Balance Sheet Optimization Transaction to refinance and extend a substantial portion of its debt, addressing upcoming maturities of its Term Loan A and Revolving Credit Agreement. For the first quarter of 2026, the company reported a net loss of $6.47 million, a significant improvement from a $24.98 million net loss in Q1 2025. Net revenue for the quarter decreased to $627.78 million from $673.88 million in the prior year.
Key Highlights
- Received commitments for a Balance Sheet Optimization Transaction to exchange and/or extend substantial debt.
- Q1 2026 net revenue decreased to $627.78 million from $673.88 million in Q1 2025.
- Q1 2026 net loss improved to $6.47 million from $24.98 million in Q1 2025.
- Basic loss per common share improved to $0.08 in Q1 2026 from $0.32 in Q1 2025.
- Operating income for Q1 2026 was $17.13 million, down from $19.79 million in Q1 2025.
- Cash and cash equivalents increased to $336.88 million at March 31, 2026, from $281.99 million at Dec 31, 2025.
- Current portion of long-term debt increased to $581.25 million at March 31, 2026, from $250.00 million at Dec 31, 2025.
- Exit and realignment income, net, was $(23.55) million in Q1 2026, compared to $13.63 million in Q1 2025.